Literature DB >> 26222760

Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease.

Yu Nakagama1,2, Ryo Inuzuka1, Taiyu Hayashi1, Takahiro Shindo1, Yoichiro Hirata1, Nobutaka Shimizu1, Jun Inatomi2, Yoshiki Yokoyama3, Yoshiyuki Namai4, Yoichiro Oda5, Masaru Takamizawa6, Yutaka Harita1, Akira Oka1.   

Abstract

BACKGROUND: Evidence to guide rescue therapy in refractory Kawasaki disease (KD) is lacking. The aim of this study was to determine the most important variables in predicting non-response to rescue therapy in refractory KD.
METHODS: We retrospectively analyzed 171 patients diagnosed with refractory KD resistant to initial i.v. immunoglobulin (IVIG). Participants received rescue therapy consisting of IVIG monotherapy or IVIG plus prednisolone. Characteristics and laboratory variables were compared between rescue therapy non-responders and responders. Multivariate logistic regression analysis was performed to determine the independent predictors of non-response to rescue therapy.
RESULTS: Among the 171 participants, 54 (31.6%) were non-responders to rescue therapy. On univariate analysis, fever pattern after initial IVIG, day of illness at rescue therapy, rescue therapy regimen and six laboratory variables (pre-IVIG sodium, C-reactive protein [CRP]; post-IVIG white blood cell count, platelet count, sodium, CRP) were useful in discriminating between non-responders and responders. These nine variables were included in multivariate logistic regression analysis. Persistent fever after initial IVIG (aOR, 2.39; 95%CI: 1.07-5.37) and post-IVIG CRP (aOR, 1.09; 95%CI: 1.02-1.17, per 1 mg/dL increase) were identified as independent predictors of non-response to rescue therapy. IVIG rescue monotherapy (aOR, 3.05; 95%CI: 1.05-8.84) also predicted non-response after adjusting for fever pattern and post-IVIG CRP.
CONCLUSIONS: Persistent fever and elevated CRP after initial IVIG are predictive of non-response to rescue therapy for refractory KD. For patients at high risk of non-response, IVIG plus prednisolone, or even further intensified rescue therapy regimens may be preferable.
© 2015 Japan Pediatric Society.

Entities:  

Keywords:  C-reactive protein; IVIG; Kawasaki disease; i.v. immunoglobulin; prednisolone

Mesh:

Substances:

Year:  2016        PMID: 26222760     DOI: 10.1111/ped.12762

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  6 in total

Review 1.  Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.

Authors:  Xuan Li; Ye Chen; Yunjia Tang; Yueyue Ding; Qiuqin Xu; Lin Sun; Weiguo Qian; Guanghui Qian; Liqiang Qin; Haitao Lv
Journal:  Eur J Pediatr       Date:  2018-06-08       Impact factor: 3.183

2.  Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.

Authors:  Yaheng Lu; Tingting Chen; Yizhou Wen; Feifei Si; Xindan Wu; Yanfeng Yang
Journal:  BMC Pediatr       Date:  2021-09-16       Impact factor: 2.125

3.  Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.

Authors:  Wei Li; Li Zhang; Zhouping Wang; Xiufang He; Huimei Lin; Yanfei Wang; Jia Yuan; Xiaofei Xie; Xu Zhang; Youzhen Qin; Ping Huang
Journal:  Int J Clin Pract       Date:  2022-08-03       Impact factor: 3.149

4.  The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study.

Authors:  Hyo Soon An; Gi Beom Kim; Mi Kyoung Song; Sang Yun Lee; Hye Won Kwon; Joo Won Lee; Eun Jung Bae
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-02       Impact factor: 3.054

5.  Incomplete Refractory Kawasaki Disease in an Infant-A Case Report and a Review of the Literature.

Authors:  Cristina O Mărginean; Lorena E Meliț; Liliana Gozar; Cristian Dan Mărginean; Maria O Mărginean
Journal:  Front Pediatr       Date:  2018-07-27       Impact factor: 3.418

6.  Biomarkers for the Discrimination of Acute Kawasaki Disease From Infections in Childhood.

Authors:  Judith Zandstra; Annemarie van de Geer; Michael W T Tanck; Diana van Stijn-Bringas Dimitriades; Cathelijn E M Aarts; Sanne M Dietz; Robin van Bruggen; Nina A Schweintzger; Werner Zenz; Marieke Emonts; Dace Zavadska; Marko Pokorn; Effua Usuf; Henriette A Moll; Luregn J Schlapbach; Enitan D Carrol; Stephane Paulus; Maria Tsolia; Colin Fink; Shunmay Yeung; Chisato Shimizu; Adriana Tremoulet; Rachel Galassini; Victoria J Wright; Federico Martinón-Torres; Jethro Herberg; Jane Burns; Michael Levin; Taco W Kuijpers
Journal:  Front Pediatr       Date:  2020-07-22       Impact factor: 3.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.